2nd Quarter - Report

AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY for AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY

Firm
Client
Income
—
Expenses
$25,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

HR 2073 and S 1572, The Child Healthcare Crisis Relief Act HR 687 and S 828, The Keeping Families Together Act HR 1424 and S 558, The Mental Health Parity Act Substance Abuse and Mental Health Services Administration Reauthorization State Childrens Mental Health Insurance Plan

LobbyistCovered position, as disclosed
KRISTIN KROEGER PTAKOWSKI Director, Government Affairs
ELIZABETH RORICK Assistant Director, Government Affairs

Contacted: Natl Institute of Mental Health (NIMH); HOUSE OF REPRESENTATIVES; Substance Abuse & Mental Health Services Administration (SAMHSA); Food & Drug Administration (FDA); SENATE

Bills named: H.R. 1424 (110th), H.R. 2073 (110th), H.R. 687 (110th)

Insurance INS

HR 1424 and S 558, Mental Health Parity Act of 2007

LobbyistCovered position, as disclosed
KRISTIN KROEGER PTAKOWSKI Director, Government Affairs
ELIZABETH RORICK Assistant Director, Government Affairs

Contacted: SENATE; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Substance Abuse & Mental Health Services Administration (SAMHSA); Natl Institute of Mental Health (NIMH)

Bills named: H.R. 1424 (110th)

Education EDU

HR 6358, Stop Child Abuse in Residential Programs for Teens

LobbyistCovered position, as disclosed
KRISTIN KROEGER PTAKOWSKI Director, Government Affairs
ELIZABETH RORICK Assistant Director, Government Affairs

Contacted: Substance Abuse & Mental Health Services Administration (SAMHSA); Food & Drug Administration (FDA); Natl Institute of Mental Health (NIMH); SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 6358 (110th)

Medical/Disease Research/Clinical Labs MED

NIH Research and Development Funding SAMHSA Program Funding Issues Regarding the Utilization of Psychotropic Drugs in Foster Care

LobbyistCovered position, as disclosed
KRISTIN KROEGER PTAKOWSKI Director, Government Affairs
ELIZABETH RORICK Assiant Director, Government Affairs

Contacted: SENATE; Substance Abuse & Mental Health Services Administration (SAMHSA); HOUSE OF REPRESENTATIVES; Natl Institute of Mental Health (NIMH); Food & Drug Administration (FDA)

Law Enforcement/Crime/Criminal Justice LAW

Juvenile Justice and Delinquency Prevention Act Reauthorization, S. 3155

LobbyistCovered position, as disclosed
KRISTIN KROEGER PTAKOWSKI Director, Government Affairs
ELIZABETH RORICK Assistant Director, Government Affairs

Contacted: Food & Drug Administration (FDA); Substance Abuse & Mental Health Services Administration (SAMHSA); Natl Institute of Mental Health (NIMH); HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 3155 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.